|
||||||
|
 | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|
Gene: ENSG00000196653 |
Summary for ZNF502 |
 Gene summary |
| Gene information | Ensembl ID | ENSG00000196653 | Gene symbol | ZNF502 |
| Gene name | zinc finger protein 502 | |
| HGNC | 23718 | |
| Entrez ID | 91392 | |
| Gene type | protein_coding | |
| Synonyms | ZNF502|FLJ14855|FLJ12515 | |
| UniProtAcc | Q8TBZ5 |
| Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for ZNF502 |
| AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure. ∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
 |
| Landscape of gene expressions across multiple cancer types. |
 |
| Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| Differentially expressed gene analysis between tumor male and normal male samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| Differentially expressed gene analysis between tumor female and normal female samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| ZNF502 | 2.26e+02 | -1.04e+00 | 1.63e-01 | -6.40e+00 | 1.51e-10 | 9.69e-10 | KIRC |
| ZNF502 | 3.02e+02 | -1.23e+00 | 1.05e-01 | -1.17e+01 | 7.38e-32 | 4.03e-31 | BRCA |
Top |
Sex-biased somatic mutation for ZNF502 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for ZNF502 |
| Landscape of DNA methylation across multiple cancer types. |
 |
| Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| PAAD | cg17279458 | chr3:44712456 | CGI:chr3:44712607-44712907 | promoter | 4.29e-01 | 5.51e-01 | 4.55e+00 | 5.44e-06 | 3.38e-05 | -1.22e-01 |
| Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| KIRC | cg11003573 | chr3:44712633 | CGI:chr3:44712607-44712907 | promoter | 1.66e-01 | 1.77e-02 | 5.87e+00 | 4.35e-09 | 3.72e-08 | 1.48e-01 |
| KIRC | cg18722847 | chr3:44712637 | CGI:chr3:44712607-44712907 | promoter | 1.58e-01 | 1.51e-02 | 6.25e+00 | 4.20e-10 | 6.50e-09 | 1.43e-01 |
| KIRC | cg15687855 | chr3:44712639 | CGI:chr3:44712607-44712907 | promoter | 2.11e-01 | 8.42e-02 | 5.29e+00 | 1.19e-07 | 5.81e-07 | 1.27e-01 |
| KIRC | cg14768256 | chr3:44713095 | CGI:chr3:44712607-44712907 | promoter,gene body | 5.97e-01 | 4.96e-01 | 2.65e+00 | 8.16e-03 | 9.97e-03 | 1.00e-01 |
| LUAD | cg24437311 | chr3:44711577 | CGI:chr3:44712607-44712907 | promoter | 7.83e-01 | 9.09e-01 | -3.29e+00 | 1.00e-03 | 1.94e-03 | -1.26e-01 |
| LUAD | cg26781129 | chr3:44712454 | CGI:chr3:44712607-44712907 | promoter | 4.04e-01 | 2.00e-01 | 3.24e+00 | 1.21e-03 | 2.27e-03 | 2.04e-01 |
| HNSC | cg10263370 | chr3:44712610 | CGI:chr3:44712607-44712907 | promoter | 1.97e-01 | 8.57e-02 | 2.22e+00 | 2.67e-02 | 2.95e-02 | 1.12e-01 |
| HNSC | cg11003573 | chr3:44712633 | CGI:chr3:44712607-44712907 | promoter | 1.79e-01 | 5.06e-02 | 2.42e+00 | 1.57e-02 | 1.88e-02 | 1.28e-01 |
| HNSC | cg18722847 | chr3:44712637 | CGI:chr3:44712607-44712907 | promoter | 1.65e-01 | 4.02e-02 | 2.31e+00 | 2.11e-02 | 2.41e-02 | 1.25e-01 |
| HNSC | cg17279458 | chr3:44712456 | CGI:chr3:44712607-44712907 | promoter | 6.00e-01 | 2.54e-01 | 3.19e+00 | 1.41e-03 | 2.42e-03 | 3.47e-01 |
| LUSC | cg10263370 | chr3:44712610 | CGI:chr3:44712607-44712907 | promoter | 2.15e-01 | 5.97e-02 | 2.84e+00 | 4.57e-03 | 7.63e-03 | 1.55e-01 |
| LUSC | cg11003573 | chr3:44712633 | CGI:chr3:44712607-44712907 | promoter | 1.99e-01 | 3.55e-02 | 2.78e+00 | 5.45e-03 | 8.70e-03 | 1.64e-01 |
| LUSC | cg18722847 | chr3:44712637 | CGI:chr3:44712607-44712907 | promoter | 1.89e-01 | 2.86e-02 | 3.08e+00 | 2.07e-03 | 4.28e-03 | 1.60e-01 |
| LUSC | cg25151919 | chr3:44712841 | CGI:chr3:44712607-44712907 | promoter,gene body | 1.29e-01 | 2.57e-02 | 2.78e+00 | 5.45e-03 | 8.70e-03 | 1.04e-01 |
| LUSC | cg24437311 | chr3:44711577 | CGI:chr3:44712607-44712907 | promoter | 8.02e-01 | 9.14e-01 | -2.35e+00 | 1.88e-02 | 2.27e-02 | -1.12e-01 |
| LUSC | cg19539664 | chr3:44711875 | CGI:chr3:44712607-44712907 | promoter | 8.35e-01 | 9.58e-01 | -3.96e+00 | 7.60e-05 | 6.28e-04 | -1.23e-01 |
| LUSC | cg26781129 | chr3:44712454 | CGI:chr3:44712607-44712907 | promoter | 3.49e-01 | 1.82e-01 | 3.18e+00 | 1.45e-03 | 3.35e-03 | 1.67e-01 |
| LUSC | cg17279458 | chr3:44712456 | CGI:chr3:44712607-44712907 | promoter | 6.48e-01 | 3.35e-01 | 3.49e+00 | 4.91e-04 | 1.64e-03 | 3.13e-01 |
| LUSC | cg15687855 | chr3:44712639 | CGI:chr3:44712607-44712907 | promoter | 2.31e-01 | 9.64e-02 | 3.00e+00 | 2.74e-03 | 5.24e-03 | 1.35e-01 |
| LIHC | cg10263370 | chr3:44712610 | CGI:chr3:44712607-44712907 | promoter | 2.37e-01 | 9.94e-02 | 2.70e+00 | 6.94e-03 | 8.81e-03 | 1.38e-01 |
| LIHC | cg11003573 | chr3:44712633 | CGI:chr3:44712607-44712907 | promoter | 2.90e-01 | 1.02e-01 | 2.90e+00 | 3.74e-03 | 5.10e-03 | 1.88e-01 |
| LIHC | cg18722847 | chr3:44712637 | CGI:chr3:44712607-44712907 | promoter | 2.53e-01 | 7.60e-02 | 2.29e+00 | 2.21e-02 | 2.45e-02 | 1.77e-01 |
| LIHC | cg24437311 | chr3:44711577 | CGI:chr3:44712607-44712907 | promoter | 6.40e-01 | 8.70e-01 | -3.08e+00 | 2.06e-03 | 3.00e-03 | -2.30e-01 |
| LIHC | cg15687855 | chr3:44712639 | CGI:chr3:44712607-44712907 | promoter | 2.78e-01 | 1.65e-01 | 2.33e+00 | 1.99e-02 | 2.23e-02 | 1.13e-01 |
| ESCA | cg17279458 | chr3:44712456 | CGI:chr3:44712607-44712907 | promoter | 6.34e-01 | 4.89e-01 | 3.04e+00 | 2.38e-03 | 3.37e-02 | 1.45e-01 |
| Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg10263370 | chr3:44712610 | CGI:chr3:44712607-44712907 | promoter | 3.18e-01 | 4.82e-02 | 1.11e+01 | 1.19e-28 | 1.48e-27 | 2.70e-01 |
| BRCA | cg11003573 | chr3:44712633 | CGI:chr3:44712607-44712907 | promoter | 3.21e-01 | 3.65e-02 | 1.10e+01 | 4.98e-28 | 5.75e-27 | 2.85e-01 |
| BRCA | cg18722847 | chr3:44712637 | CGI:chr3:44712607-44712907 | promoter | 3.14e-01 | 3.54e-02 | 1.08e+01 | 2.85e-27 | 3.04e-26 | 2.79e-01 |
| BRCA | cg25151919 | chr3:44712841 | CGI:chr3:44712607-44712907 | promoter,gene body | 2.63e-01 | 2.58e-02 | 1.18e+01 | 4.10e-32 | 7.82e-31 | 2.37e-01 |
| BRCA | cg24437311 | chr3:44711577 | CGI:chr3:44712607-44712907 | promoter | 7.98e-01 | 9.05e-01 | -5.78e+00 | 7.52e-09 | 1.70e-08 | -1.06e-01 |
| BRCA | cg19539664 | chr3:44711875 | CGI:chr3:44712607-44712907 | promoter | 7.56e-01 | 9.57e-01 | -1.28e+01 | 1.89e-37 | 8.54e-36 | -2.01e-01 |
| BRCA | cg26781129 | chr3:44712454 | CGI:chr3:44712607-44712907 | promoter | 5.31e-01 | 1.59e-01 | 2.96e+00 | 3.06e-03 | 3.74e-03 | 3.71e-01 |
| BRCA | cg21672276 | chr3:44712580 | CGI:chr3:44712607-44712907 | promoter | 2.45e-01 | 8.72e-02 | 9.78e+00 | 1.38e-22 | 9.38e-22 | 1.58e-01 |
| BRCA | cg15687855 | chr3:44712639 | CGI:chr3:44712607-44712907 | promoter | 3.24e-01 | 9.31e-02 | 1.09e+01 | 1.19e-27 | 1.32e-26 | 2.31e-01 |
| BRCA | cg15604051 | chr3:44712709 | CGI:chr3:44712607-44712907 | UTR,promoter,exon,gene body | 2.36e-01 | 8.95e-02 | 1.03e+01 | 1.05e-24 | 8.69e-24 | 1.46e-01 |
| KIRC | cg13919821 | chr3:44712373 | CGI:chr3:44712607-44712907 | promoter | 5.97e-01 | 4.76e-01 | 2.35e+00 | 1.87e-02 | 2.57e-02 | 1.20e-01 |
| COAD | cg19539664 | chr3:44711875 | CGI:chr3:44712607-44712907 | promoter | 8.04e-01 | 9.34e-01 | -2.03e+00 | 4.24e-02 | 4.43e-02 | -1.30e-01 |
| BLCA | cg14768256 | chr3:44713095 | CGI:chr3:44712607-44712907 | promoter,gene body | 5.28e-01 | 6.67e-01 | -2.28e+00 | 2.27e-02 | 2.95e-02 | -1.40e-01 |
Top |
Exon skipping events with PSI in TCGA for ZNF502 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
| Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for ZNF502 |
| ∗Please access CAeditome for RNA editing annotation. |
| Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for ZNF502 |
| TFs related to ZNF502. ∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| DLBC | ZNF235 | ZNF502 | 5.01e+00 | 1.40e-02 | 5.83e+00 | 9.85e-01 | Female-biased |
| DLBC | ZNF287 | ZNF502 | 4.93e+00 | 1.58e-02 | 5.71e+00 | 9.83e-01 | Female-biased |
| DLBC | ZNF487 | ZNF502 | 4.72e+00 | 1.72e-02 | 5.47e+00 | 9.81e-01 | Female-biased |
| MESO | ZBTB17 | ZNF502 | 4.05e+00 | 9.83e-01 | 2.58e+00 | 3.87e-03 | Male-biased |
| READ | ZNF235 | ZNF502 | 5.01e+00 | 1.62e-02 | 5.73e+00 | 9.83e-01 | Female-biased |
| SKCM | ZNF22 | ZNF502 | 4.31e+00 | 1.19e-02 | 5.23e+00 | 9.83e-01 | Female-biased |
| SKCM | ZNF225 | ZNF502 | 4.57e+00 | 1.29e-02 | 5.47e+00 | 9.84e-01 | Female-biased |
| SKCM | ZNF879 | ZNF502 | 5.05e+00 | 1.32e-02 | 5.95e+00 | 9.85e-01 | Female-biased |
| THYM | ZNF879 | ZNF502 | 4.25e+00 | 1.34e-02 | 4.87e+00 | 9.82e-01 | Female-biased |
| ZNF502 related gene. ∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
 |
Top |
Sex-biased RBP-ES network for ZNF502 |
| RBPs related to ES in ZNF502. ∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| ZNF502 related ES. ∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
| Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
| ENSG00000196653 | KRTAP5-AS1,hsa-mir-10b,ZNF502 | Female-specific ceRNA | TCGA-KIRC |
Top |
Sex-biased eQTL regulation of gene |
| Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
| Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs9852733 | chr3:44235847:C:T | - | 0.117302084808325 | 0.01267961962606 | STAD | Female-baised eQTL |
| rs6793863 | chr3:44217371:G:A | - | 0.115834967552285 | 0.0143295248203517 | STAD | Female-baised eQTL |
| rs4325903 | chr3:44220041:A:G | - | 0.115834967552285 | 0.0143295248203517 | STAD | Female-baised eQTL |
| rs10510741 | chr3:44222702:G:A | - | 0.115834967552285 | 0.0143295248203517 | STAD | Female-baised eQTL |
| rs4682959 | chr3:44236807:T:C | - | 0.115834967552285 | 0.0143295248203517 | STAD | Female-baised eQTL |
| rs4682955 | chr3:44227867:G:A | - | 0.115863760819784 | 0.0165314124687375 | STAD | Female-baised eQTL |
| rs4392391 | chr3:44231474:G:A | - | 0.115863760819784 | 0.0165314124687375 | STAD | Female-baised eQTL |
| rs4392392 | chr3:44231825:G:A | - | 0.115863760819784 | 0.0165314124687375 | STAD | Female-baised eQTL |
| rs967285 | chr3:44233784:C:T | - | 0.115863760819784 | 0.0165314124687375 | STAD | Female-baised eQTL |
| rs6808448 | chr3:44202115:G:T | - | 0.113117660662553 | 0.0168329170679128 | STAD | Female-baised eQTL |
| rs4682950 | chr3:44203982:G:T | - | 0.113117660662553 | 0.0168329170679128 | STAD | Female-baised eQTL |
| rs2129957 | chr3:44207534:G:C | - | 0.113117660662553 | 0.0168329170679128 | STAD | Female-baised eQTL |
| rs9861600 | chr3:44209212:A:G | - | 0.113117660662553 | 0.0168329170679128 | STAD | Female-baised eQTL |
| rs4682952 | chr3:44212337:G:C | - | 0.113422437757869 | 0.0185555813959688 | STAD | Female-baised eQTL |
| rs12715399 | chr3:44212949:C:A | - | 0.113422437757869 | 0.0185555813959688 | STAD | Female-baised eQTL |
| rs34953201 | chr3:44209863:A:G | - | 0.113212348615007 | 0.0208489459973061 | STAD | Female-baised eQTL |
| rs9846155 | chr3:44241348:A:G | - | 0.112158486078267 | 0.0221026033515096 | STAD | Female-baised eQTL |
| rs9311351 | chr3:44239009:C:G | - | 0.112181720530407 | 0.025036540181834 | STAD | Female-baised eQTL |
| rs4682732 | chr3:44239777:A:G | - | 0.112181720530407 | 0.025036540181834 | STAD | Female-baised eQTL |
| rs9836139 | chr3:44239847:A:G | - | 0.112181720530407 | 0.025036540181834 | STAD | Female-baised eQTL |
| rs4682733 | chr3:44240855:C:T | - | 0.112181720530407 | 0.025036540181834 | STAD | Female-baised eQTL |
| rs9809107 | chr3:44241442:G:A | - | 0.112181720530407 | 0.025036540181834 | STAD | Female-baised eQTL |
| rs4682725 | chr3:44200103:A:T | - | 0.109027522101319 | 0.027124882571052 | STAD | Female-baised eQTL |
| rs9864257 | chr3:44403162:G:A | - | 0.111277284590972 | 0.0316787867172223 | STAD | Female-baised eQTL |
| rs9859565 | chr3:44284832:A:C | - | 0.108467140628663 | 0.0329284007491809 | STAD | Female-baised eQTL |
| rs9681701 | chr3:44247881:T:C | - | 0.108247682972013 | 0.0337519758461448 | STAD | Female-baised eQTL |
| rs9842445 | chr3:44249093:T:G | - | 0.108247682972013 | 0.0337519758461448 | STAD | Female-baised eQTL |
| rs13067367 | chr3:44251783:T:C | - | 0.108247682972013 | 0.0337519758461448 | STAD | Female-baised eQTL |
| rs9311352 | chr3:44252347:C:G | - | 0.108247682972013 | 0.0337519758461448 | STAD | Female-baised eQTL |
| rs9839422 | chr3:44252589:G:A | - | 0.108247682972013 | 0.0337519758461448 | STAD | Female-baised eQTL |
| rs9835626 | chr3:44253152:T:A | - | 0.108247682972013 | 0.0337519758461448 | STAD | Female-baised eQTL |
| rs4682734 | chr3:44253682:G:T | - | 0.108247682972013 | 0.0337519758461448 | STAD | Female-baised eQTL |
| rs4682736 | chr3:44254378:G:A | - | 0.108247682972013 | 0.0337519758461448 | STAD | Female-baised eQTL |
| rs4682960 | chr3:44254911:T:C | - | 0.108247682972013 | 0.0337519758461448 | STAD | Female-baised eQTL |
| rs1387042 | chr3:44258274:G:A | - | 0.108247682972013 | 0.0337519758461448 | STAD | Female-baised eQTL |
| rs9821268 | chr3:44261632:A:G | - | 0.108247682972013 | 0.0337519758461448 | STAD | Female-baised eQTL |
| rs11130023 | chr3:44266396:A:G | - | 0.108247682972013 | 0.0337519758461448 | STAD | Female-baised eQTL |
| rs1844147 | chr3:44268413:G:T | - | 0.108247682972013 | 0.0337519758461448 | STAD | Female-baised eQTL |
| rs9873869 | chr3:44269903:C:T | - | 0.108247682972013 | 0.0337519758461448 | STAD | Female-baised eQTL |
| rs7621060 | chr3:44272930:A:G | - | 0.108247682972013 | 0.0337519758461448 | STAD | Female-baised eQTL |
| rs996764 | chr3:44280846:T:C | - | 0.108247682972013 | 0.0337519758461448 | STAD | Female-baised eQTL |
| rs1387046 | chr3:44282622:C:G | - | 0.108247682972013 | 0.0337519758461448 | STAD | Female-baised eQTL |
| rs7649004 | chr3:44283979:G:C | - | 0.108247682972013 | 0.0337519758461448 | STAD | Female-baised eQTL |
| rs7641332 | chr3:44284090:T:C | - | 0.108247682972013 | 0.0337519758461448 | STAD | Female-baised eQTL |
| rs7639096 | chr3:44284138:A:G | - | 0.108247682972013 | 0.0337519758461448 | STAD | Female-baised eQTL |
| rs4682963 | chr3:44288469:G:A | - | 0.108247682972013 | 0.0337519758461448 | STAD | Female-baised eQTL |
| rs9311353 | chr3:44290025:A:G | - | 0.108247682972013 | 0.0337519758461448 | STAD | Female-baised eQTL |
| rs6803491 | chr3:44291661:T:A | - | 0.108247682972013 | 0.0337519758461448 | STAD | Female-baised eQTL |
| rs1565214 | chr3:44292807:C:A | - | 0.108247682972013 | 0.0337519758461448 | STAD | Female-baised eQTL |
| rs1565212 | chr3:44293002:A:G | - | 0.108247682972013 | 0.0337519758461448 | STAD | Female-baised eQTL |
| rs7619532 | chr3:44294009:G:A | - | 0.108247682972013 | 0.0337519758461448 | STAD | Female-baised eQTL |
| rs6776788 | chr3:44295420:G:C | - | 0.108247682972013 | 0.0337519758461448 | STAD | Female-baised eQTL |
| rs6780605 | chr3:44296750:G:A | - | 0.108247682972013 | 0.0337519758461448 | STAD | Female-baised eQTL |
| rs6772940 | chr3:44297709:A:G | - | 0.108247682972013 | 0.0337519758461448 | STAD | Female-baised eQTL |
| rs7619094 | chr3:44299545:G:A | - | 0.108247682972013 | 0.0337519758461448 | STAD | Female-baised eQTL |
| rs4682743 | chr3:44395396:A:C | - | 0.109712631466152 | 0.0360134860905952 | STAD | Female-baised eQTL |
| rs4682976 | chr3:44397752:A:G | - | 0.109712631466152 | 0.0360134860905952 | STAD | Female-baised eQTL |
| rs7433407 | chr3:44398279:A:T | - | 0.109712631466152 | 0.0360134860905952 | STAD | Female-baised eQTL |
| rs13080889 | chr3:44398511:C:T | - | 0.109712631466152 | 0.0360134860905952 | STAD | Female-baised eQTL |
| rs7653843 | chr3:44403849:C:T | - | 0.109712631466152 | 0.0360134860905952 | STAD | Female-baised eQTL |
| rs35875034 | chr3:44200338:T:G | - | 0.112221199714073 | 0.0375396154361374 | STAD | Female-baised eQTL |
| rs1873048 | chr3:44217744:C:T | - | 0.111217741799194 | 0.0489818909518781 | STAD | Female-baised eQTL |
| rs17368353 | chr3:44953636:C:T | - | 0.080663567305849 | 0.00478523480142809 | LUAD | Female-baised eQTL |
| rs78362605 | chr3:53687824:G:A | - | 0.163565130992353 | 0.017589890354914 | LUAD | Female-baised eQTL |
| rs4683148 | chr3:45914568:C:T | - | 0.0661054775550965 | 0.0270540289614368 | LUAD | Female-baised eQTL |
| rs9831315 | chr3:45914870:G:C | - | 0.0656911162782658 | 0.029141470662121 | LUAD | Female-baised eQTL |
| rs3733103 | chr3:45921103:C:G | - | 0.06504277430811 | 0.0391336251297936 | LUAD | Female-baised eQTL |
| Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs9868357 | chr3:46629262:A:G | - | 0.253978804492745 | 0.00238619942104425 | READ | Male-baised eQTL |
| rs36174833 | chr3:46629595:T:C | - | 0.253978804492745 | 0.00238619942104425 | READ | Male-baised eQTL |
| rs72906128 | chr3:46629726:G:C | - | 0.253978804492745 | 0.00238619942104425 | READ | Male-baised eQTL |
| rs78837944 | chr3:46629822:G:A | - | 0.253978804492745 | 0.00238619942104425 | READ | Male-baised eQTL |
| rs9819159 | chr3:46623418:T:C | - | 0.22768629071632 | 0.0145662390696354 | READ | Male-baised eQTL |
| rs9836993 | chr3:46623630:A:G | - | 0.22768629071632 | 0.0145662390696354 | READ | Male-baised eQTL |
| rs72904287 | chr3:46623775:G:A | - | 0.22768629071632 | 0.0145662390696354 | READ | Male-baised eQTL |
| rs11928922 | chr3:46624349:G:T | - | 0.22768629071632 | 0.0145662390696354 | READ | Male-baised eQTL |
| rs111636876 | chr3:46624461:A:G | - | 0.22768629071632 | 0.0145662390696354 | READ | Male-baised eQTL |
| rs111518116 | chr3:46624517:A:G | - | 0.22768629071632 | 0.0145662390696354 | READ | Male-baised eQTL |
| rs9880885 | chr3:46624857:G:T | - | 0.22768629071632 | 0.0145662390696354 | READ | Male-baised eQTL |
| rs9829227 | chr3:46625031:T:C | - | 0.22768629071632 | 0.0145662390696354 | READ | Male-baised eQTL |
| rs9810013 | chr3:46625303:G:A | - | 0.22768629071632 | 0.0145662390696354 | READ | Male-baised eQTL |
| rs3796367 | chr3:46625463:A:G | - | 0.22768629071632 | 0.0145662390696354 | READ | Male-baised eQTL |
| rs3796368 | chr3:46625588:T:C | - | 0.22768629071632 | 0.0145662390696354 | READ | Male-baised eQTL |
| rs3796369 | chr3:46625620:A:G | - | 0.22768629071632 | 0.0145662390696354 | READ | Male-baised eQTL |
| rs3796370 | chr3:46625693:C:A | - | 0.22768629071632 | 0.0145662390696354 | READ | Male-baised eQTL |
| rs9834713 | chr3:46626198:T:C | - | 0.22768629071632 | 0.0145662390696354 | READ | Male-baised eQTL |
| rs9835025 | chr3:46626390:T:C | - | 0.22768629071632 | 0.0145662390696354 | READ | Male-baised eQTL |
| rs9852808 | chr3:46626487:A:G | - | 0.22768629071632 | 0.0145662390696354 | READ | Male-baised eQTL |
| rs59157540 | chr3:46626590:C:T | - | 0.22768629071632 | 0.0145662390696354 | READ | Male-baised eQTL |
| rs11919792 | chr3:46626677:T:C | - | 0.22768629071632 | 0.0145662390696354 | READ | Male-baised eQTL |
| rs11915788 | chr3:46626764:G:T | - | 0.22768629071632 | 0.0145662390696354 | READ | Male-baised eQTL |
| rs35165054 | chr3:46627004:C:A | - | 0.22768629071632 | 0.0145662390696354 | READ | Male-baised eQTL |
| rs9820361 | chr3:46627364:C:T | - | 0.22768629071632 | 0.0145662390696354 | READ | Male-baised eQTL |
| rs9820372 | chr3:46627387:C:G | - | 0.22768629071632 | 0.0145662390696354 | READ | Male-baised eQTL |
| rs9820785 | chr3:46627507:G:A | - | 0.22768629071632 | 0.0145662390696354 | READ | Male-baised eQTL |
| rs9820845 | chr3:46627687:C:G | - | 0.22768629071632 | 0.0145662390696354 | READ | Male-baised eQTL |
| rs9820861 | chr3:46627704:C:G | - | 0.22768629071632 | 0.0145662390696354 | READ | Male-baised eQTL |
| rs9821418 | chr3:46627832:G:A | - | 0.22768629071632 | 0.0145662390696354 | READ | Male-baised eQTL |
| rs9841203 | chr3:46627859:T:C | - | 0.22768629071632 | 0.0145662390696354 | READ | Male-baised eQTL |
| rs9841229 | chr3:46627902:T:C | - | 0.22768629071632 | 0.0145662390696354 | READ | Male-baised eQTL |
| rs72906115 | chr3:46627949:C:T | - | 0.22768629071632 | 0.0145662390696354 | READ | Male-baised eQTL |
| rs34727142 | chr3:46628073:C:A | - | 0.22768629071632 | 0.0145662390696354 | READ | Male-baised eQTL |
| rs34671776 | chr3:46628204:T:C | - | 0.22768629071632 | 0.0145662390696354 | READ | Male-baised eQTL |
| rs34256467 | chr3:46628251:A:G | - | 0.22768629071632 | 0.0145662390696354 | READ | Male-baised eQTL |
| rs34326471 | chr3:46628580:T:G | - | 0.22768629071632 | 0.0145662390696354 | READ | Male-baised eQTL |
| rs61621072 | chr3:46628589:G:T | - | 0.22768629071632 | 0.0145662390696354 | READ | Male-baised eQTL |
| rs9864097 | chr3:46628873:A:G | - | 0.22768629071632 | 0.0145662390696354 | READ | Male-baised eQTL |
| rs7642843 | chr3:44786301:T:C | - | 0.047597539297055 | 0.0199716753718702 | BLCA | Male-baised eQTL |
| rs2372831 | chr3:44788044:G:A | - | 0.047597539297055 | 0.0199716753718702 | BLCA | Male-baised eQTL |
| rs937834 | chr3:44762231:C:T | - | 0.0469562777004597 | 0.023996002254049 | BLCA | Male-baised eQTL |
| rs7653392 | chr3:44764384:C:T | - | 0.0469562777004597 | 0.023996002254049 | BLCA | Male-baised eQTL |
| rs6441867 | chr3:44768615:C:T | - | 0.0469562777004597 | 0.023996002254049 | BLCA | Male-baised eQTL |
| rs10865935 | chr3:44769084:T:A | - | 0.0469562777004597 | 0.023996002254049 | BLCA | Male-baised eQTL |
| rs1973547 | chr3:44774902:T:C | - | 0.0469562777004597 | 0.023996002254049 | BLCA | Male-baised eQTL |
| rs55814136 | chr3:44776563:A:G | - | 0.0469562777004597 | 0.023996002254049 | BLCA | Male-baised eQTL |
| rs7650535 | chr3:44786184:G:C | - | 0.0469643919016831 | 0.0247239160141029 | BLCA | Male-baised eQTL |
| rs2372830 | chr3:44788034:C:T | - | 0.0469643919016831 | 0.0247239160141029 | BLCA | Male-baised eQTL |
| rs1965379 | chr3:44794006:G:A | - | 0.0469643919016831 | 0.0247239160141029 | BLCA | Male-baised eQTL |
| rs1463950 | chr3:44794081:A:G | - | 0.0463719268635113 | 0.0272307382087599 | BLCA | Male-baised eQTL |
| rs6792299 | chr3:44749708:T:A | - | 0.045892568958364 | 0.0304631592280289 | BLCA | Male-baised eQTL |
| rs3749199 | chr3:44754557:G:C | - | 0.045892568958364 | 0.0304631592280289 | BLCA | Male-baised eQTL |
| rs1876223 | chr3:44761331:G:A | - | 0.045892568958364 | 0.0304631592280289 | BLCA | Male-baised eQTL |
| rs62244227 | chr3:44792250:T:C | - | 0.0455361906884146 | 0.0341252153503686 | BLCA | Male-baised eQTL |
| rs6780236 | chr3:44750548:C:T | - | 0.0453968350803115 | 0.0356101041785278 | BLCA | Male-baised eQTL |
| rs11926748 | chr3:44840826:G:A | - | 0.0448070254061183 | 0.043676703940607 | BLCA | Male-baised eQTL |
| rs77137609 | chr3:35414108:C:A | - | 0.172874883733318 | 4.31363755345006e-05 | COAD | Male-baised eQTL |
| rs9879442 | chr3:35409406:G:C | - | 0.101621209601827 | 0.0051118231196088 | COAD | Male-baised eQTL |
| rs56338456 | chr3:35411811:T:G | - | 0.100626870338451 | 0.0058532720125162 | COAD | Male-baised eQTL |
| rs7627785 | chr3:35418751:G:A | - | 0.100626870338451 | 0.0058532720125162 | COAD | Male-baised eQTL |
| rs9822654 | chr3:35423663:G:C | - | 0.100626870338451 | 0.0058532720125162 | COAD | Male-baised eQTL |
| rs6765172 | chr3:35427544:T:C | - | 0.100626870338451 | 0.0058532720125162 | COAD | Male-baised eQTL |
| rs6786371 | chr3:44780094:G:A | - | 0.0620699051603197 | 0.00820754519465479 | COAD | Male-baised eQTL |
| rs11926748 | chr3:44840826:G:A | - | 0.0561683423491147 | 0.0214948080360323 | COAD | Male-baised eQTL |
| rs11720680 | chr3:48117742:A:G | - | 0.141020773282592 | 0.0243626679945655 | COAD | Male-baised eQTL |
| rs7650535 | chr3:44786184:G:C | - | 0.0548747371957849 | 0.0272141630437592 | COAD | Male-baised eQTL |
| rs2372830 | chr3:44788034:C:T | - | 0.0548747371957849 | 0.0272141630437592 | COAD | Male-baised eQTL |
| rs62244227 | chr3:44792250:T:C | - | 0.0548747371957849 | 0.0272141630437592 | COAD | Male-baised eQTL |
| rs1965379 | chr3:44794006:G:A | - | 0.0548747371957849 | 0.0272141630437592 | COAD | Male-baised eQTL |
| rs1880480 | chr3:41252216:T:A | - | -0.0502346983018282 | 0.036335835089958 | COAD | Male-baised eQTL |
| rs2372827 | chr3:44772581:A:G | - | 0.0570685493738083 | 0.0481286537420875 | COAD | Male-baised eQTL |
| Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
| Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
 | Gene ID: ENSG00000196653 |
| CpG Site: cg14768256 | |
| Position to Gene: gene,promoter | |
| Male Effect: -0.314831111440118 | |
| Female Effect: - |
| Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg14768256 | chr3:44713095 | gene,promoter | -0.314831111440118 | 4.67293580359472e-05 | -0.342096075660355 | 1.616286132226151e-07 | LUAD |
| Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
| Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
| Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
| Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
| Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of ZNF502 |
| Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
